Company / Current Liabilities
BioAge Labs, Inc. Current Liabilities History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$20.1M
FY2025
5-year range
$20.1M / $58.2M
FY2023-FY2025
Trend
-27.5%
vs FY2024
Sector context
#190 of 213
Health Care
What the data says
BioAge Labs, Inc.'s current liabilities of $20M is lower than 89% of companies in the Health Care sector (FY2025). Improved from $58M to $20M over the past 2 years.
Based on SEC 10-K filings.
$20M in FY2025.
Improved from $58M to $20M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 213This company $20.1M Sector average $1.6B
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, current liabilities decreased 27.5% year-over-year.
- Ranks #190 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.1M | -27.5% |
| FY2024 | $27.8M | -52.3% |
| FY2023 | $58.2M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026